Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Alemtuzumab (CAMPATH 1-H) Therapy in Sporadic Inclusion Body Myositis (sIBM): A Treatment Trial in Patients with Established Natural History Data
Muscle Disease/Neuromuscular Junction
(-)
001
Authors/Disclosures
Marinos C. Dalakas, MD, FÂé¶¹´«Ã½Ó³»­ (Thomas Jefferson University) Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Âé¶¹´«Ã½Ó³»­. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Goran Rakocevic, MD, FÂé¶¹´«Ã½Ó³»­ (Thomas Jefferson University) Dr. Rakocevic has nothing to disclose.
No disclosure on file
Carol Moore (Henry Jackson Foundation/USUHS) No disclosure on file
Mohammad Salajegheh, MD, FÂé¶¹´«Ã½Ó³»­ (VA Boston Healthcare System) Dr. Salajegheh has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with US Department of Veterans Affairs. Dr. Salajegheh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with CRICO.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file